ImStar Therapeutics' Seed Round

ImStar Therapeutics raised a round of funding on June 10, 2016.

ImStar Therapeutics is a biotechnology company developing a breakthrough new approach to treating Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's Disease. ImStar Therapeutics is developing treatm…

Articles about ImStar Therapeutics' Seed Round: